KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
KindlyMD Announces Second Quarter 2024 Financial Results and Provides Shareholder Update
Company provides nearly 80% statewide comprehensive insurance coverage in Utah under contract with providers such as Medicare, Select Health, Medicaid, and Blue Cross Blue Shield
根据与医疗保险、精选健康、医疗补助和蓝十字蓝盾等提供商签订的合同,公司在犹他州提供近80%的全州综合保险
Reimbursement from insurance payors increased 163.7% sequentially and is expected to increase as a percentage of total revenue going forward
保险支付人的报销额连续增长了163.7%,预计未来占总收入的百分比将增加
Reimbursements from insurance payors totaled $126,325 in first half of 2024 as compared to $0 during the first half of 2023
2024年上半年,保险支付人的报销总额为126,325美元,而2023年上半年为0美元
SALT LAKE CITY, UT / ACCESSWIRE / August 14, 2024 / KindlyMD, Inc. ("KindlyMD" or the "Company") (NASDAQ:KDLY), a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies, today announced its financial results for the second quarter ended June 30, 2024 and is providing a shareholder update.
犹他州盐湖城/ACCESSWIRE/2024年8月14日/KindlyMD, Inc.(“KindlyMD” 或 “公司”)(纳斯达克股票代码:KDLY)是一家以患者为先的医疗保健和医疗保健数据公司,将传统的初级保健和疼痛管理策略与综合行为和替代疗法独特地整合在一起,今天公布了截至2024年6月30日的第二季度财务业绩,并提供了股东最新情况。
Tim Pickett, PA-C, KindlyMD Founder and CEO, stated, "During the second quarter we successfully closed on our IPO for gross proceeds of approximately $6 million. While from a total revenue perspective during the quarter we did not yet yield the return on investment from the additional working capital we received, we are very pleased with the 163.7% sequential growth in reimbursement from insurance payors. As Utah's first alternative medical treatment company to contract under the state's top insurance payors, we are laser focused on growing this segment of our revenue stream. We are now proud to provide nearly 80% of statewide comprehensive insurance coverage to the Utah community, through top providers including Medicare, Select Health, Medicaid, and Blue Cross Blue Shield, according to the 2023 Utah Health Insurance Market Report. We are working to continue this growth trend, particularly as we invest in the acquisition of new patients to our facilities."
KindlyMD创始人兼首席执行官PA-C蒂姆·皮克特表示:“在第二季度,我们成功完成了首次公开募股,总收益约为600万美元。尽管从总收入的角度来看,我们在本季度尚未从收到的额外营运资金中获得投资回报,但我们对保险支付人报销额连续增长163.7%感到非常满意。作为犹他州第一家与该州最高保险支付方签订合同的替代医疗公司,我们专注于发展收入来源的这一部分。根据2023年犹他州健康保险市场报告,我们现在很自豪能够通过包括医疗保险、精选健康、医疗补助和蓝十字蓝盾在内的顶级提供商向犹他州社区提供近80%的全州综合保险。我们正在努力延续这一增长趋势,尤其是在我们投资为我们的设施招收新患者时。”
"Our team is also focused on aggressive growth via accretive acquisitions of clinics in Utah to expand our footprint. As a leader in the market, we see significant opportunity to potentially acquire profitable locations and integrate onto our platform driving operational synergies and margin expansion. The market is highly fragmented, and our potential pipeline remains robust. We look forward to updating our shareholders on our progress in the near future."
“我们的团队还专注于通过增值收购犹他州的诊所来实现积极增长,以扩大我们的足迹。作为市场领导者,我们看到了巨大的机会,可以收购盈利的地点并整合到我们的平台上,从而推动运营协同效应和利润扩大。市场高度分散,我们的潜在渠道仍然强劲。我们期待在不久的将来向股东通报我们的最新进展。”
Operational Highlights:
运营亮点:
Completed IPO in June 2024 for net proceeds of $6.02 million
Achieved nearly 80% statewide comprehensive insurance coverage in Utah according to the 2023 Utah Health Insurance Market Report
Became Utah's first alternative medical treatment company to contract under the state's top insurance payors, which now include Medicare, Select Health and Medicaid and Blue Cross Blue Shield
Collaborated with Curaleaf to expand patient education on medical cannabis care in Utah with community care events held at multiple Curaleaf Utah medical cannabis pharmacies
Successfully registered on SAM.gov, the official U.S. federal funding platform
2024 年 6 月完成首次公开募股,净收益为 602 万美元
根据2023年犹他州健康保险市场报告,犹他州实现了近80%的全州综合保险覆盖率
成为犹他州第一家与该州最高保险支付方签订合同的替代医疗公司,这些支付方现在包括医疗保险、精选健康和医疗补助以及蓝十字蓝盾
与Curaleaf合作,在犹他州Curaleaf的多家医用大麻药房举办社区护理活动,扩大犹他州患者对医用大麻护理的教育
在美国官方联邦资助平台 SAM.gov 上成功注册
Subsequent Events:
后续事件:
Submitted a comment to the U.S. Department of Justice, following its recent proposed rule to reclassify cannabis from Schedule I to Schedule III of the Controlled Substances Act
在美国司法部最近提出将大麻从《管制物质法》附表一改为附表三的规则之后,向美国司法部提交了评论意见
Financial Highlights for the Quarterly Period Ended June 30, 2024
截至2024年6月30日的季度财务摘要
The Company earned $91,553 in reimbursements from insurance payors during the three months ending June 30, 2024, an increase of 163.7% over the $34,722 earned for the three months ending March 31, 2024. The Company earned $126,325 in reimbursements from insurance payors during the six months ended June 30, 2024, as compared to $0 during the three and six months ended June 30, 2023.
在截至2024年6月30日的三个月中,公司从保险支付人那里获得了91,553美元的报销,比截至2024年3月31日的三个月的34,722美元增长了163.7%。在截至2024年6月30日的六个月中,公司从保险支付人那里获得了126,325美元的报销,而在截至2023年6月30日的三个月和六个月中,该报销额为0美元。
Revenues decreased by $340,481, or 34.8%, to $639,057 for the three months ended June 30, 2024, from $979,538 for the three months ended June 30, 2023. The decrease in revenues is primarily attributed to a decrease in cash-pay patient care services as KindlyMD continues to shift toward insurance billing with commercial and governmental payers including Medicare, Medicaid, Select Health, Blue Cross Blue Shield, and other commercial payers compared to the prior period.
截至2024年6月30日的三个月,收入从截至2023年6月30日的三个月的979,538美元下降了340,481美元,至639,057美元,跌幅34.8%。收入下降的主要原因是与前一时期相比,KindlyMD继续转向由包括Medicare、Medicaid、Select Health、蓝十字蓝盾和其他商业付款人在内的商业和政府付款人的保险账单,现金支付的患者护理服务减少。
Operating expenses increased by $95,423, or 6.0%, to $1,676,250 for the three months ended June 30, 2024, from $1,580,827 for the three months ended June 30, 2023. The increase in operating expenses is primarily attributable to an increase in general and administrative expenses, salaries and wages, and cost of revenues.
截至2024年6月30日的三个月,运营费用从截至2023年6月30日的三个月的1,580,827美元增加了95,423美元,增幅6.0%,至1,676,250美元。运营费用的增加主要归因于一般和管理费用、薪金和工资以及收入成本的增加。
Net loss per share decreased by $0.13, or 100.0%, to $(0.26) for the three months ended June 30, 2024, compared to $(0.13) for the three months ended June 30, 2023. KindlyMD management strives to look for opportunities to optimize revenue by increasing sales, acquiring additional clinics, improving margins, and controlling ongoing operating expenses.
截至2024年6月30日的三个月,每股净亏损下降了0.13美元,至0.26美元,跌幅100.0%,而截至2023年6月30日的三个月,每股净亏损为0.13美元(0.13美元)。KindlyMD 管理层努力通过增加销售额、收购更多诊所、提高利润率和控制持续运营支出来寻找优化收入的机会。
As of June 30, 2024, the Company had cash and cash equivalents of $4.74 million and total working capital of $4.11 million.
截至2024年6月30日,该公司的现金及现金等价物为474万美元,营运资金总额为411万美元。
In June 2024, KindlyMD completed its IPO for total net proceeds of $6.02 million, providing adequate liquidity and cash reserves to meet its obligations for at least the 12-month period following June 30, 2024, and to assist the Company in implementing its strategic operational business plans to create sustained cash flow generation thereafter.
2024年6月,KindlyMD完成了首次公开募股,总净收益为602万美元,提供了充足的流动性和现金储备,以履行其在2024年6月30日之后的至少12个月期间的债务,并协助公司实施其战略运营业务计划,以创造持续的现金流。
As of August 9, 2024, the Company had 5,947,169 common shares outstanding.
截至2024年8月9日,该公司的已发行普通股为5,947,169股。
About KindlyMD
关于 KindlyMD
KindlyMD is a patient-first healthcare and healthcare data company uniquely integrating traditional primary care and pain management strategies with integrated behavioral and alternative therapies to offer patients comprehensive care and reduce the addiction and dependency of opioid use in the U.S. KindlyMD currently operates four centers, including the largest alternative pain treatment center in Utah. With a focus on holistic pain management through its specialty outpatient clinical services, including, where appropriate, the recommendation of medical cannabis by KindlyMD healthcare providers, KindlyMD is providing better patient health outcomes.
KindlyMD 是一家以患者为先的医疗保健和医疗保健数据公司,独特地将传统的初级保健和疼痛管理策略与综合行为和替代疗法相结合,为患者提供全面护理,减少美国阿片类药物使用的成瘾和依赖。KindlyMD 目前运营四个中心,包括犹他州最大的替代性疼痛治疗中心。KindlyMD 专注于通过其专业门诊临床服务(酌情包括 KindlyMD 医疗保健提供者推荐的医用大麻)进行全面的疼痛管理,为患者提供更好的健康结果。
For more information, please visit .
欲了解更多信息,请访问。
Forward-Looking Statements
前瞻性陈述
This press release contains certain forward-looking statements that are based upon current expectations and involve certain risks and uncertainties within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Such forward-looking statements can be identified by the use of words such as "should," "may," "intends," "anticipates," "believes," "estimates," "projects," "forecasts," "expects," "plans," and "proposes." These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and other factors, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. You are urged to carefully review and consider any cautionary statements and other disclosures, including the statements made under the heading "Risk Factors" in KindlyMD, Inc.'s Annual Report on Form 10-K for the fiscal year ended December 31, 2022. KindlyMD, Inc. does not undertake any duty to update any forward-looking statements except as may be required by law. The information which appears on our websites and our social media platforms, including, but not limited to, Instagram and Facebook, is not part of this press release.
本新闻稿包含某些前瞻性陈述,这些陈述基于当前预期,涉及1995年《美国私人证券诉讼改革法》所指的某些风险和不确定性。此类前瞻性陈述可以通过使用 “应该”、“可能”、“打算”、“预期”、“相信”、“估计”、“项目”、“预测”、“期望”、“计划” 和 “提议” 等词语来识别。这些前瞻性陈述不能保证未来的表现,并受风险、不确定性和其他因素的影响,其中一些因素是我们无法控制的,难以预测,可能导致实际结果与前瞻性陈述中表达或预测的结果存在重大差异。我们敦促您仔细审查和考虑任何警示声明和其他披露,包括在 KindlyMD, Inc. “风险因素” 标题下发表的声明。”截至2022年12月31日的财政年度的10-K表年度报告。除非法律要求,否则KindlyMD, Inc.不承担任何更新任何前瞻性陈述的责任。出现在我们的网站和社交媒体平台(包括但不限于Instagram和Facebook)上的信息不在本新闻稿中。
Investor Relations Contact:
投资者关系联系人:
Valter Pinto, Managing Director
KCSA Strategic Communications
(212) 896-1254
KindlyMD@KCSA.com
瓦尔特·平托,董事总经理
KCSA 战略传播
(212) 896-1254
KindlyMD@KCSA.com
KINDLY MD, INC.
CONDENSED BALANCE SHEETS
谢谢 MD, INC.
简明的资产负债表
June 30, 2024 |
December 31, 2023 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current Assets |
||||||||
Cash and cash equivalents |
$ |
4,740,006 |
$ |
525,500 |
||||
Accounts receivable |
5,182 |
28,001 |
||||||
Inventories, net |
3,825 |
63,202 |
||||||
Prepaid expenses and other current assets |
305,655 |
225 |
||||||
Total Current Assets |
5,054,668 |
616,928 |
||||||
Property and equipment, net |
206,816 |
235,292 |
||||||
Operating lease right-of-use assets |
184,177 |
235,706 |
||||||
Security deposits |
11,276 |
11,276 |
||||||
TOTAL ASSETS |
$ |
5,456,937 |
$ |
1,099,202 |
||||
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
||||||||
Current Liabilities |
||||||||
Accounts payable and accrued expenses |
$ |
628,749 |
$ |
329,810 |
||||
Customer deposits |
4,150 |
3,425 |
||||||
Current portion of operating lease liabilities |
79,973 |
94,696 |
||||||
Current portion of finance lease liabilities |
2,010 |
- |
||||||
Current portion of notes payable, net |
228,061 |
148,517 |
||||||
Derivative liability |
- |
238,000 |
||||||
Total Current Liabilities |
942,943 |
814,448 |
||||||
Operating lease liabilities, net of current portion |
124,651 |
164,295 |
||||||
Finance lease liabilities, net of current portion |
8,635 |
|||||||
Notes payable, net of current portion |
- |
228,871 |
||||||
TOTAL LIABILITIES |
1,076,229 |
1,207,614 |
||||||
Stockholders' Equity (Deficit) |
||||||||
Preferred Stock, $0.001 par value, 10,000,000 shares authorized; none issued and outstanding as of June 30, 2024 and December 31, 2023 |
- |
- |
||||||
Common stock, $0.001 par value, 100,000,000 shares authorized; 5,939,516 and 4,617,798 shares issued and outstanding as of June 30, 2024 and December 31, 2023, respectively |
5,940 |
4,618 |
||||||
Additional paid-in capital |
10,134,801 |
4,045,024 |
||||||
Accumulated deficit |
(5,760,033) | (4,158,054) | ||||||
TOTAL STOCKHOLDERS' EQUITY (DEFICIT) |
4,380,708 |
(108,412) | ||||||
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) |
$ |
5,456,937 |
$ |
1,099,202 |
2024年6月30日 |
2023 年 12 月 31 日 |
|||||||
(未经审计) |
||||||||
资产 |
||||||||
流动资产 |
||||||||
现金和现金等价物 |
$ |
4,740,006 |
$ |
525,500 |
||||
应收账款 |
5,182 |
28,001 |
||||||
库存,净额 |
3,825 |
63,202 |
||||||
预付费用和其他流动资产 |
305,655 |
225 |
||||||
流动资产总额 |
5,054,668 |
616,928 |
||||||
财产和设备,净额 |
206,816 |
235,292 |
||||||
经营租赁使用权资产 |
184,177 |
235,706 |
||||||
保证金 |
11,276 |
11,276 |
||||||
总资产 |
$ |
5,456,937 |
$ |
1,099,202 |
||||
负债和股东权益(赤字) |
||||||||
流动负债 |
||||||||
应付账款和应计费用 |
$ |
628,749 |
$ |
329,810 |
||||
客户存款 |
4,150 |
3,425 |
||||||
经营租赁负债的流动部分 |
79,973 |
94,696 |
||||||
融资租赁负债的流动部分 |
2,010 |
- |
||||||
应付票据的当期部分,净额 |
228,061 |
148,517 |
||||||
衍生责任 |
- |
238,000 |
||||||
流动负债总额 |
942,943 |
814,448 |
||||||
经营租赁负债,扣除流动部分 |
124,651 |
164,295 |
||||||
融资租赁负债,扣除流动部分 |
8,635 |
|||||||
应付票据,扣除流动部分 |
- |
228,871 |
||||||
负债总额 |
1,076,229 |
1,207,614 |
||||||
股东权益(赤字) |
||||||||
优先股,面值0.001美元,已获授权1,000万股;截至2024年6月30日和2023年12月31日,未发行和流通股票 |
- |
- |
||||||
普通股,面值0.001美元,授权1亿股;截至2024年6月30日和2023年12月31日,已发行和流通的股票分别为5,939,516和4,617,798股 |
5,940 |
4,618 |
||||||
额外的实收资本 |
10,134,801 |
4,045,024 |
||||||
累计赤字 |
(5,760,033) | (4,158,054) | ||||||
股东权益总额(赤字) |
4,380,708 |
(108,412) | ||||||
总负债和股东权益(赤字) |
$ |
5,456,937 |
$ |
1,099,202 |
KINDLY MD, INC.
CONDENSED STATEMENTS OF OPERATIONS
(UNAUDITED)
谢谢 MD, INC.
简明的运营报表
(未经审计)
For the Three Months Ended
June 30,
|
For the Six Months Ended
June 30,
|
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
Revenues |
$ |
639,057 |
$ |
979,538 |
$ |
1,468,086 |
$ |
2,139,883 |
||||||||
Operating Expenses |
||||||||||||||||
Cost of revenues |
61,947 |
59,508 |
69,691 |
108,132 |
||||||||||||
Salaries and wages |
1,126,893 |
1,109,559 |
1,834,859 |
2,042,860 |
||||||||||||
General and administrative |
461,677 |
385,536 |
787,222 |
743,719 |
||||||||||||
Depreciation |
25,733 |
26,224 |
50,634 |
51,666 |
||||||||||||
Total Operating Expenses |
1,676,250 |
1,580,827 |
2,742,406 |
2,946,377 |
||||||||||||
LOSS FROM OPERATIONS |
(1,037,193) | (601,289) | (1,274,320) | (806,494) | ||||||||||||
Other Income (Expenses) |
||||||||||||||||
Other income |
13,828 |
13,075 |
25,868 |
37,301 |
||||||||||||
Interest expense |
(318,450) | (8,194) | (375,689) | (8,194) | ||||||||||||
Loss on extinguishment of debt |
(38,889) | (38,889) | ||||||||||||||
Gain on change in fair value of derivative liability |
61,051 |
- |
61,051 |
- |
||||||||||||
Total Other Income (Expenses) |
(282,460) | 4,881 |
(327,659) | 29,107 |
||||||||||||
NET LOSS BEFORE INCOME TAXES |
(1,319,653) | (596,408) | (1,601,979) | (777,387) | ||||||||||||
INCOME TAX EXPENSE |
- |
- |
- |
- |
||||||||||||
NET LOSS |
$ |
(1,319,653) | $ |
(596,408) | $ |
(1,601,979) | $ |
(777,387) | ||||||||
LOSS PER COMMON SHARE - BASIC AND DILUTED |
$ |
(0.26) | $ |
(0.13) | $ |
(0.33) | $ |
(0.17) | ||||||||
WEIGHTED-AVERAGE NUMBER OF SHARES OUTSTANDING - BASIC AND DILUTED |
5,009,956 |
4,455,912 |
4,813,877 |
4,445,714 |
在已结束的三个月中
6月30日
|
在已结束的六个月中
6月30日
|
|||||||||||||||
2024 |
2023 |
2024 |
2023 |
|||||||||||||
收入 |
$ |
639,057 |
$ |
979,538 |
$ |
1,468,086 |
$ |
2,139,883 |
||||||||
运营费用 |
||||||||||||||||
收入成本 |
61,947 |
59,508 |
69,691 |
108,132 |
||||||||||||
薪金和工资 |
1,126,893 |
1,109,559 |
1,834,859 |
2,042,860 |
||||||||||||
一般和行政 |
461,677 |
385,536 |
787,222 |
743,719 |
||||||||||||
折旧 |
25,733 |
26,224 |
50,634 |
51,666 |
||||||||||||
总运营费用 |
1,676,250 |
1,580,827 |
2,742,406 |
2,946,377 |
||||||||||||
运营损失 |
(1,037,193) | (601,289) | (1,274,320) | (806,494) | ||||||||||||
其他收入(支出) |
||||||||||||||||
其他收入 |
13,828 |
13,075 |
25,868 |
37,301 |
||||||||||||
利息支出 |
(318,450) | (8,194) | (375,689) | (8,194) | ||||||||||||
债务消灭造成的损失 |
(38,889) | (38,889) | ||||||||||||||
衍生负债公允价值变动所得收益 |
61,051 |
- |
61,051 |
- |
||||||||||||
其他收入总额(支出) |
(282,460) | 4,881 |
(327,659) | 29,107 |
||||||||||||
所得税前净亏损 |
(1,319,653) | (596,408) | (1,601,979) | (777,387) | ||||||||||||
所得税支出 |
- |
- |
- |
- |
||||||||||||
净亏损 |
$ |
(1,319,653) | $ |
(596,408) | $ |
(1,601,979) | $ |
(777,387) | ||||||||
普通股每股亏损——基本亏损和摊薄亏损 |
$ |
(0.26) | $ |
(0.13) | $ |
(0.33) | $ |
(0.17) | ||||||||
已发行股票的加权平均数——基本股和摊薄股票 |
5,009,956 |
4,455,912 |
4,813,877 |
4,445,714 |
KINDLY MD, INC.
CONDENSED STATEMENTS OF CASH FLOWS
(UNAUDITED)
谢谢 MD, INC.
简明的现金流量表
(未经审计)
For the Six Months Ended |
||||||||
2024 |
2023 |
|||||||
CASH FLOWS FROM OPERATING ACTIVITIES |
||||||||
Net loss |
$ |
(1,601,979) | $ |
(777,387) | ||||
Adjustments to reconcile loss to net cash used in operating activities: |
||||||||
Stock-based compensation |
15,500 |
338,021 |
||||||
Depreciation expense |
50,634 |
51,666 |
||||||
Loss on extinguishment of debt |
38,889 |
- |
||||||
Gain on change in fair value of derivative liability |
(61,051) | - |
||||||
Amortization of debt discounts |
357,439 |
876 |
||||||
Amortization of right-of-use assets |
51,529 |
61,589 |
||||||
Changes in operating assets and liabilities: |
||||||||
Accounts receivable |
22,819 |
4,161 |
||||||
Inventories |
59,377 |
(9,822) | ||||||
Prepaid expenses and other current assets |
(305,430) | 11,039 |
||||||
Security deposits |
- |
731 |
||||||
Accounts payable and accrued expenses |
298,939 |
106,668 |
||||||
Customer deposits |
725 |
300 |
||||||
Operating lease liabilities |
(54,367) | (62,806) | ||||||
Net cash used in operating activities |
(1,126,976) | (274,964) | ||||||
CASH FLOWS FROM INVESTING ACTIVITIES |
||||||||
Purchases of property and equipment |
(11,182) | (14,420) | ||||||
Net cash used in investing activities |
(11,182) | (14,420) | ||||||
CASH FLOWS FROM FINANCING ACTIVITIES |
||||||||
Net proceeds from issuance of notes payable |
45,000 |
- |
||||||
Net proceeds from issuance of related party note payable |
233,373 |
|||||||
Net proceeds from issuance of common shares and warrants in connection with a public offering |
5,860,650 |
- |
||||||
Repayments of related party note payable |
- |
(20,282) | ||||||
Repayments of notes payable |
(552,655) | - |
||||||
Repayments of finance lease liabilities |
(331) | - |
||||||
Net cash provided by financing activities |
5,352,664 |
213,091 |
||||||
NET CHANGE IN CASH AND CASH EQUIVALENTS |
4,214,506 |
(76,293) | ||||||
CASH AND CASH EQUIVALENTS |
||||||||
Beginning of the period |
525,500 |
186,918 |
||||||
End of the period |
$ |
4,740,006 |
$ |
110,625 |
||||
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION |
||||||||
Cash paid for interest |
$ |
19,089 |
$ |
- |
||||
Cash paid for income taxes |
$ |
- |
$ |
- |
||||
NON-CASH INVESTING AND FINANCING ACTIVITIES |
||||||||
Debt discounts on notes payable |
$ |
10,556 |
$ |
- |
||||
Debt discount on related party note payable |
$ |
- |
$ |
16,627 |
||||
Fair value of derivative liability recognized upon issuance of notes payable |
$ |
38,000 |
$ |
- |
||||
Extinguishment of derivative liability upon settlement of notes payable |
$ |
214,949 |
$ |
- |
||||
Finance purchases of property and equipment |
$ |
10,976 |
$ |
- |
在已结束的六个月中 |
||||||||
2024 |
2023 |
|||||||
来自经营活动的现金流 |
||||||||
净亏损 |
$ |
(1,601,979) | $ |
(777,387) | ||||
为将亏损与经营活动中使用的净现金进行核对而进行的调整: |
||||||||
基于股票的薪酬 |
15,500 |
338,021 |
||||||
折旧费用 |
50,634 |
51,666 |
||||||
债务消灭造成的损失 |
38,889 |
- |
||||||
衍生负债公允价值变动所得收益 |
(61,051) | - |
||||||
债务折扣的摊销 |
357,439 |
876 |
||||||
使用权资产的摊销 |
51,529 |
61,589 |
||||||
运营资产和负债的变化: |
||||||||
应收账款 |
22,819 |
4,161 |
||||||
库存 |
59,377 |
(9,822) | ||||||
预付费用和其他流动资产 |
(305,430) | 11,039 |
||||||
保证金 |
- |
731 |
||||||
应付账款和应计费用 |
298,939 |
106,668 |
||||||
客户存款 |
725 |
300 |
||||||
经营租赁负债 |
(54,367) | (62,806) | ||||||
用于经营活动的净现金 |
(1,126,976) | (274,964) | ||||||
来自投资活动的现金流 |
||||||||
购买财产和设备 |
(11,182) | (14,420) | ||||||
用于投资活动的净现金 |
(11,182) | (14,420) | ||||||
来自融资活动的现金流量 |
||||||||
发行应付票据的净收益 |
45,000 |
- |
||||||
发行关联方应付票据的净收益 |
233,373 |
|||||||
发行与公开发行相关的普通股和认股权证的净收益 |
5,860,650 |
- |
||||||
关联方应付票据的还款 |
- |
(20,282) | ||||||
应付票据的还款 |
(552,655) | - |
||||||
偿还融资租赁负债 |
(331) | - |
||||||
融资活动提供的净现金 |
5,352,664 |
213,091 |
||||||
现金和现金等价物的净变化 |
4,214,506 |
(76,293) | ||||||
现金和现金等价物 |
||||||||
时期开始 |
525,500 |
186,918 |
||||||
期末 |
$ |
4,740,006 |
$ |
110,625 |
||||
现金流信息的补充披露 |
||||||||
支付利息的现金 |
$ |
19,089 |
$ |
- |
||||
为所得税支付的现金 |
$ |
- |
$ |
- |
||||
非现金投资和融资活动 |
||||||||
应付票据的债务折扣 |
$ |
10,556 |
$ |
- |
||||
关联方应付票据的债务折扣 |
$ |
- |
$ |
16,627 |
||||
发行应付票据时确认的衍生负债的公允价值 |
$ |
38,000 |
$ |
- |
||||
应付票据结算后的衍生负债的消除 |
$ |
214,949 |
$ |
- |
||||
为购买财产和设备提供资金 |
$ |
10,976 |
$ |
- |
SOURCE: KindlyMD, Inc
资料来源:KindlyMD, Inc